Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - International Stem Cell CORP | d846584d8k.htm |
Exhibit 99.1
International Stem Cell Corporation and Subsidiaries
Condensed Pro Forma Consolidated Balance Sheet
(in thousands, except share data)
| September 30, 2014 |
Pro Forma | September 30, 2014 |
||||||||||
| As Reported | Adjustments | Pro Forma | ||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||
| Assets |
||||||||||||
| Cash and cash equivalents |
$ | 471 | $ | — | $ | 471 | ||||||
| Accounts receivable, net of allowance for doubtful accounts of $19 |
464 | — | 464 | |||||||||
| Inventory, net |
1,533 | — | 1,533 | |||||||||
| Prepaid expenses and other current assets |
359 | — | 359 | |||||||||
| Restricted cash |
50 | — | 50 | |||||||||
|
|
|
|
|
|||||||||
| Total current assets |
2,877 | — | 2,877 | |||||||||
| Property and equipment, net |
781 | — | 781 | |||||||||
| Intangible assets, net |
2,649 | — | 2,649 | |||||||||
| Deposits and other assets |
57 | — | 57 | |||||||||
|
|
|
|
|
|||||||||
| Total assets |
$ | 6,364 | $ | — | $ | 6,364 | ||||||
|
|
|
|
|
|||||||||
| Liabilities, Redeemable Preferred Stock and Stockholders’ Equity (Deficit) |
||||||||||||
| Accounts payable |
$ | 715 | $ | — | $ | 715 | ||||||
| Accrued liabilities |
1,299 | — | 1,299 | |||||||||
| Deferred revenue |
— | — | — | |||||||||
| Related party payable |
5 | — | 5 | |||||||||
| Advances |
250 | — | 250 | |||||||||
| Fair value of warrant liability |
— | — | — | |||||||||
|
|
|
|
|
|||||||||
| Total current liabilities |
2,269 | — | 2,269 | |||||||||
|
|
|
|
|
|||||||||
| Convertible Redeemable Series G Preferred stock, $0.001 par value, 5,000,000 shares authorized, issued and outstanding and liquidation preference of $5,000 |
4,941 | (4,941 | ) | — | ||||||||
| Commitments and contingencies |
||||||||||||
| Stockholders’ Deficit |
||||||||||||
| Series D Preferred stock, $0.001 par value, 50 shares authorized, 43 issued and outstanding with liquidation preference of $4,320 |
— | — | — | |||||||||
| Series B Preferred stock, $0.001 par value, 5,000,000 shares authorized, 300,000 issued and outstanding with liquidation preferences of $417 |
— | — | — | |||||||||
| Common stock, $0.001 par value, 600,000,000 shares authorized, 224,274,073 shares issued and outstanding |
224 | — | 224 | |||||||||
| Convertible Series G Preferred stock, $0.001 par value, 5,000,000 shares authorized, issued and outstanding, liquidation preference of $5,000 |
— | 4,941 | 4,941 | |||||||||
| Additional paid-in capital |
89,080 | — | 89,080 | |||||||||
| Accumulated deficit |
(90,150 | ) | — | (90,150 | ) | |||||||
|
|
|
|
|
|||||||||
| Total stockholders’ deficit |
(846 | ) | 4,941 | 4,095 | ||||||||
|
|
|
|
|
|||||||||
| Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) |
$ | 6,364 | $ | — | $ | 6,364 | ||||||
|
|
|
|
|
|||||||||